# Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

> **NCT00281736** · PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 60 (estimated)

## Conditions studied

- Esophageal Cancer
- Precancerous Condition

## Interventions

- **DRUG:** HPPH

## Key facts

- **NCT ID:** NCT00281736
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2007-07
- **Final completion:** 2013-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00281736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00281736, "Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00281736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*